George A Cates

Title: George A. Cates: Innovator in Immunogenic Compositions

Introduction

George A. Cates is a notable inventor based in Richmond Hill, Canada. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 6 patents to his name, Cates has focused on developing immunogenic compositions that enhance immune responses.

Latest Patents

One of Cates' latest patents is titled "Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation." This patent describes immunogenic compositions designed for adults, especially the elderly, to protect against diseases caused by respiratory syncytial virus (RSV) and influenza virus. The composition includes a mixture of purified fusion (F) protein, attachment (G) protein, and matrix (M) protein of RSV, along with a non-virulent influenza virus preparation. Importantly, the components do not impair each other's immunogenicity when formulated as a vaccine for in vivo administration. Additionally, the immunogenic composition may contain an adjuvant to further enhance its effectiveness.

Another significant patent by Cates is the "Method for delivery of antigens to selected cells of the immune system using chimeric antibodies." This patent discloses antibody molecules that are specific for surface structures of antigen-presenting cells. These molecules have been genetically modified to include an antigen moiety, resulting in novel conjugate antibody molecules. The conjugate antibodies retain specificity for antigen-presenting cells and effectively deliver the antigen to enhance the immune response in hosts immunized with them. These conjugate antibody molecules and their encoding nucleic acid molecules have valuable applications in diagnostics and prophylactic treatments.

Career Highlights

Throughout his career, George A. Cates has worked with prominent companies in the biotechnology and pharmaceutical sectors. Notably, he has been associated with Aventis Pasteur Limited and Connaught Laboratories Limited. His work in these organizations has contributed to advancements in vaccine development and immunology.

Collaborations

Cates has collaborated with several professionals in his field, including Michel Henri Klein and Mary E. Ewasyshyn. Their combined expertise has likely fostered innovative approaches to immunogenic research and development.

Conclusion

George A. Cates stands out as an influential inventor in the realm of immunogenic compositions. His patents reflect a commitment to enhancing immune responses,